BAD HOMBURG VOR DER HOEHE (dpa-AFX) - Fresenius (FSNPF.PK, FSNUF.PK, FRE.DE), a German healthcare company, on Monday reaffirmed its annual adjusted earnings growth guidance.
For fiscal 2026, excluding Fresenius Medical Care and Vitrea, the company still expects core earnings per share growth of 5% to 10%. For fiscal 2025, the Group had reported core earnings of EUR 2.87 per share.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News




